1. Home
  2. TATT vs RIGL Comparison

TATT vs RIGL Comparison

Compare TATT & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TATT
  • RIGL
  • Stock Information
  • Founded
  • TATT 1985
  • RIGL 1996
  • Country
  • TATT Israel
  • RIGL United States
  • Employees
  • TATT N/A
  • RIGL N/A
  • Industry
  • TATT Aerospace
  • RIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • TATT Industrials
  • RIGL Health Care
  • Exchange
  • TATT Nasdaq
  • RIGL Nasdaq
  • Market Cap
  • TATT 308.2M
  • RIGL 334.5M
  • IPO Year
  • TATT 1987
  • RIGL 2000
  • Fundamental
  • Price
  • TATT $34.14
  • RIGL $18.77
  • Analyst Decision
  • TATT Strong Buy
  • RIGL Buy
  • Analyst Count
  • TATT 1
  • RIGL 5
  • Target Price
  • TATT $35.00
  • RIGL $36.40
  • AVG Volume (30 Days)
  • TATT 140.6K
  • RIGL 191.2K
  • Earning Date
  • TATT 05-21-2025
  • RIGL 05-06-2025
  • Dividend Yield
  • TATT N/A
  • RIGL N/A
  • EPS Growth
  • TATT 96.08
  • RIGL N/A
  • EPS
  • TATT 1.00
  • RIGL 2.08
  • Revenue
  • TATT $152,116,000.00
  • RIGL $203,077,000.00
  • Revenue This Year
  • TATT $18.62
  • RIGL $12.53
  • Revenue Next Year
  • TATT $10.62
  • RIGL $15.68
  • P/E Ratio
  • TATT $34.74
  • RIGL $9.10
  • Revenue Growth
  • TATT 33.68
  • RIGL 70.16
  • 52 Week Low
  • TATT $11.84
  • RIGL $7.48
  • 52 Week High
  • TATT $33.83
  • RIGL $29.82
  • Technical
  • Relative Strength Index (RSI)
  • TATT 69.05
  • RIGL 51.63
  • Support Level
  • TATT $28.58
  • RIGL $16.88
  • Resistance Level
  • TATT $33.83
  • RIGL $25.42
  • Average True Range (ATR)
  • TATT 1.93
  • RIGL 1.46
  • MACD
  • TATT 0.67
  • RIGL 0.08
  • Stochastic Oscillator
  • TATT 80.30
  • RIGL 22.13

About TATT TAT Technologies Ltd.

TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Share on Social Networks: